CaMKII is an abundant synaptic protein strongly implicated in plasticity. Overexpression of autonomous (T286D) CaMKII in CA1 hippocampal cells enhances synaptic strength if T305/T306 sites are not phosphorylated, but decreases synaptic strength if they are phosphorylated. It has generally been thought that spine size and synaptic strength covary; however, the ability of CaMKII and its various phosphorylation states to control spine size has not been previously examined. Using a unique method that allows the effects of overexpressed protein to be monitored over time, we found that all autonomous forms of CaMKII increase spine size. Thus, for instance, the T286D/T305D/T306D form increases spine size but decreases synaptic strength. Further evidence for such dissociation is provided by experiments with the T286D form that has been made catalytically dead. This form fails to enhance synaptic strength but increases spine size, presumably by a structural process. Thus very different mechanisms govern how CaMKII affects spine structure and synaptic function.
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synaptic plasticity | structural plasticity | autophosphorylation | nonenzymatic function S tudies have shown that there are structural correlates of synaptic plasticity. Photolysis of caged glutamate at individual spines produces long-term potentiation (LTP) and is accompanied by a persistent increase in spine size (1, 2) . Similarly, the induction of long-term depression (LTD) causes spine shrinkage (3) . Moreover, the spines on a dendrite vary dramatically in size (4) in a manner that correlates with the postsynaptic strength of the synapse on that spine (5, 6) .
CaMKII is one of the most abundant proteins in the brain (7) . It is activated during LTP (8, 9) , an activation that is required for potentiation (10) (11) (12) . This activation is dependent on phosphorylation at T286, which makes the enzyme autonomous of Ca 2+ /calmodulin (13) . The instructive role of CaMKII in the control of synaptic strength has been examined by overexpression of various phosphorylation states of the kinase. Recent work (14) revealed that the effect of the autonomous form (T286D) has unexpected complexity that depends on additional phosphorylation sites (T305/T306). These sites have been previously implicated in metaplasticity (15) . If these sites are not phosphorylated (T286D/T305A/T306A), potentiation is produced that occludes LTP (14) . However, if the sites are pseudophosphorylated (T286D/T305D/T305D), depression is produced that occludes LTD (14) . Given the correlation of synaptic strength and spine size noted above, we expected that the forms of CaMKII that increase synaptic strength would increase spine size, whereas those that decrease synaptic strength would decrease spine size. We tested this prediction and found that it is not correct. Autonomous CaMKII forms increase spine size regardless of whether synaptic strength is increased or decreased. The mechanisms by which CaMKII affects spine structure and synaptic strength thus have a different dependence on the phosphorylation state of the enzyme. This difference is underscored by a further finding: that a T286D form with an additional mutation that blocks enzymatic activity can enhance spine size, but has no effect on synaptic strength. Thus, very different mechanisms couple CaMKII to structural and functional changes.
Results
To examine the instructive role of CaMKII in spine enlargement, we first expressed the unactivated wild-type (WT) form of αCaMKII tagged with monomeric green fluorescent protein (GFP-αCaMKII). Experiments were done on pyramidal neurons of CA1 in cultured hippocampal slices. We estimate that the level of expressed protein (WT) at the soma was approximately three times that of the endogenous level (14) . The expression level of other CaMKII mutants used in this study was not measured quantitatively, but fluorescent brightness was comparable to WT. Spine density and volume of WT were very similar to those of GFP controls [density, WT = 5.5 ± 0.26 (spines/10 μm), GFP = 5.5 ± 0.19; volume, WT = 0.40 ± 0.038 (μm 3 ), GFP = 0.39 ± 0.033], indicating that such expression of unactivated CaMKII did not affect spine morphology ( Fig. 1 B and C) . Previous work indicates that unactivated CaMKII also had no effect on synaptic strength (Fig. 2C) (14) .
We next examined cells in which CaMKII is overexpressed in an activated state. CaMKII is normally inactive because an autoinhibitory domain binds to the catalytic domain. During activation by Ca 2+ /calmodulin, the kinase becomes autophosphorylated at T286, blocking the action of the autoinhibitory domain and making the enzyme autonomously active after removal of Ca 2+ / calmodulin (13) . To determine the role of this autonomous state of CaMKII in structural plasticity, we expressed GFP-αCaMKII with a mutation T286D (mimicking phosphorylation) or T286A (preventing autophosphorylation). After ∼24 h, secondary and tertiary dendritic branches in a region ∼100 μm away from the soma were imaged (Fig. 1A) . In cells transfected with T286D the average spine size was~30% larger than in cells transfected with only GFP (Fig. 1C) . The autonomous form (T286D) also produced an ∼30% increase in spine density compared with control conditions (GFP and WT) (Fig. 1B) . In contrast, the T286A form had no effect on spine density or size ( Fig. 1 B and C) . The increase in spine volume and density by T286D is interesting because our previous work showed that T286D in this condition produces synaptic depression (Fig. 2C ) that occludes LTD (14) . Taken together, the results not only indicate that autophosphorylation at T286 is sufficient to increase spine volume and density, but also suggest that CaMKII can differentially regulate structure and function.
The results described above involved cross-cell comparisons and are therefore subject to some limitations (e.g., the increase in average spine size could result from the formation of new, unusually large spines). To monitor morphological changes directly, we developed a unique method, dual sequential transfection (DST), that allows cross-time comparison of identified spines. In this method (Fig. 3A) , single-cell electroporation (SCE) was performed on the target neuron to introduce mCherry as a morphological marker. After allowing 24 h for expression, a baseline image of spines in a region of interest (ROI) was obtained. The neuron was then transfected with one of the αCaMKII variants. The next day, the same ROI was imaged, allowing comparison of individual spines before and after αCaMKII expression. Examples of raw data on spines observed by DST are presented in SI Appendix, Fig. S1 . DST itself did not change cell properties such as resting membrane potential and dendritic spine morphology [resting membrane potentials: nontransfected (mV) = 60.0 ± 0.71, transfected (DST) = 61.3 ± 0.35, n = 2].
Using the DST method, we found that T286D produced both an increase in the volume of identified spines and the formation of new spines (Fig. 3 B , Cd, and Dd). No significant change in spine density or volume was produced by GFP, WT, or T286A (Fig. 3) . We also estimated the changes in spine volume using an alternative analysis method (SI Appendix, Fig. S2 ; Materials and Methods) and found similar results (SI Appendix, Fig. S2I ). Thus, both cross-cell comparison and the DST method demonstrate that the T286D form increases spine volume and density. This result stands in contrast to the decrease in synaptic strength produced by this form (Fig. 2C) .
Previous work (14) suggests that phosphorylation of T305/ T306 sites is necessary for the T286D form to produce weakening. The evidence for this result is that the phosphomimetic mutant T286D/T305D/T306D produces synaptic depression, whereas a mutant that prevents phosphorylation at these sites (T286D/T305A/T306A) produces potentiation (Fig. 2C) . It was thus of interest to test whether phosphorylation of the T305/ T306 sites affected spine properties. The results show that both forms similarly increase spine volume and density (Fig. 4) . Thus, whereas phosphorylation of T305/T306 sites dramatically affects synaptic strength, it does not affect spine structure.
These results bear on an additional issue. The autophosphorylation at T286 is known to increase calmodulin trapping (16) , and the resulting decrease in the free calmodulin concentration might alter other calmodulin-dependent pathways and thereby lead to the increase in spine size. However, as shown above, T286D/ T305D/T306D, a mutant that is autonomously active (17) but cannot bind calmodulin, also increases spine size. Thus the increase in spine volume and density produced by CaMKII is not a secondary consequence of changes in calmodulin binding.
CaMKII-dependent plasticity is triggered by N-methyl-Daspartic acid receptor (NMDAR) activity (18, 19) , and there is ongoing NMDAR activity produced by spontaneous neural activity in slice culture (20, 21) . To investigate whether such NMDAR activity is required for T286D-dependent spine plasticity, an NMDAR blocker, D-2-amino-5-phosphonopentanoate (APV; 100 μM) was added to the culture medium immediately after the second transfection (with T286D). Structural potentiation ∼24 h later still occurred under these conditions (Fig. 4 Bb and Cb), indicating that the T286D mutant can produce spine enlargement without NMDAR activation.
The results so far indicate that the autonomous form of CaMKII is sufficient to increase spine size and density. A truncated form (1-290; tCaMKII) is constitutively active but unable to form holoenzymes (22) and is deficient in binding to some anchoring proteins. Several studies have shown that tCaMKII potentiates synaptic strength that occludes LTP (11, 14, 23, 24) . We wondered if tCaMKII can reproduce the structural effects of autonomous CaMKII. We found that tCaMKII produced no increase in spine density (Fig. 4Ba) , indicating that enzymatic activity alone is not sufficient for new spine formation. We also monitored how tCaMKII affected spine morphology. There were effects, but these were very different from those produced by T286D: The majority of spines (∼60%) lost their neck and became stubby shaped or merged to dendritic shafts ( Fig. 5 A and Ba). To quantify this change, spine length (the distance between the dendritic shaft and the tip of the spine; Fig. 5A ) was measured. tCaMKII produced a marked decrease in spine length, whereas there were no significant changes by T286D, WT, and T286A (Fig. 5B) . When the volume analysis was performed on spines that had a clear boundary between spines and dendrites, there was no significant change in volume (Fig. 4Ca) (this volume analysis cannot exclude the possibility that spines that lose their necks might increase total volume). The morphological changes produced by tCaMKII were not influenced by preincubation with APV (thus, data were combined). We conclude that tCaMKII does not mimic the effect of T286D on either spine formation or spine enlargement.
CaMKII is so abundant in the postsynaptic density (PSD) that a structural role for the enzyme was postulated (7). Each subunit can bind several postsynaptic proteins (25, 26) , providing the possibility for the dodecamer holoenzyme to form a multimolecular complex. This binding is often facilitated by autophosphorylation at T286 but does not require subsequent enzymatic activity (26, 27) . Indeed, in short-term presynaptic plasticity and proteasome recruitment, a nonenzymatic function of autonomous CaMKII has been demonstrated (28, 29) . Thus, perhaps, once autophosphorylated, CaMKII affects postsynaptic structure nonenzymatically. To explore this possibility, we performed DST with a T286D form that also contains an additional mutation that prevents catalytic activity (K42R/T286D) (SI Appendix, Fig.  S3 ) (30, 31) . Remarkably, this form still increased spine density and volume (Fig. 4 A, Be, and Ce). This result suggests that, once tCaMKII: density (before) = 6.0 ± 0.41 (spines/10 μm), density (after) = 6.0 ± 0.36, n = 8, P = 0.885. (Bii) The inhibition of NMDAR by APV does not prevent T286D-dependent density increase. T286D (APV): density (before) = 6.3 ± 0.45 (spines/10 μm), density (after) = 7.5 ± 0.45, n = 8, P < 0.01. (Biii) T286D/T305D/ T306D increases spine density. T286D/T305D/T306D: density (before) = 6.6 ± 0.36 (spines/10 μm), density (after) = 7.9 ± 0.39, n = 9, P < 0.01. (Biv) T286D/ T305A/T306A increases spine density. T286D/T305A/T306A: density (before) = 6.3 ± 0.55 (spines/10 μm), density (after) = 7.4 ± 0.58, n = 10, P < 0.05. (Bv) The genetic inhibition of kinase activity does not prevent T286D-dependent density increase. K42R/T286D: density (before) = 5.6 ± 0.27, density (after) = 6.9 ± 0.38, n = 9, P < 0.01. phosphorylated at T286, CaMKII does not require further kinase activity to produce spine enlargement.
K42R/T286D can stimulate new spine formation and spine enlargement. We wondered whether this structural potentiation is accompanied by an increase in synaptic strength. To examine this, excitatory postsynaptic currents (EPSCs) were measured from neurons transfected with K42R/T286D and compared with neighboring nontransfected neurons. The results showed that K42R/ T286D failed to increase synaptic strength and in fact decreased synaptic strength (Fig. 2C) . Thus, kinase activity of the T286D form is required to enhance synaptic strength although it is not required for spine growth.
Discussion
Our results indicate that the structural and functional effects of autonomous CaMKII can be dissociated because they depend on different phosphorylation states of CaMKII. For functional plasticity (i.e., synaptic strength), the phosphorylation of T305/T306 is a control point (14) . If these sites are not phosphorylated, strengthening is produced; if these sites are phosphorylated, weakening is produced. In contrast, once activated, CaMKII leads to spine enlargement irrespective of whether T305/T306 gets phosphorylated. This can lead to some dramatic dissociations; notably T286D/T305D/T306D increases spine volume, but decreases synaptic strength. The dissociation of structure and function also can depend on mechanistic actions of the kinase. We found that the spine enlargement does not require further enzyme activity once CaMKII is autophosphorylated; in contrast, further kinase activity is required to produce an increase in synaptic strength (Fig. 2C) . Taken together, these results clearly show the different phosphorylation states and properties of CaMKII control structure and function.
The observation that LTP is associated with an increase in spine volume (2) has led to the view that spine size can be taken as an indicator of synaptic strength. Our results indicate that this assumption must be made with caution. This indication is consistent with other work questioning this assumption (32) (33) (34) .
Our results show that the T286D mutant is sufficient to enlarge spines, thus providing direct evidence for this capability. Taken together with previous work suggesting that CaMKII activity is necessary for spine enlargement during LTP (2), our work points to αCaMKII as a critical control point in the determination of spine size.
Nonenzymatic Process by Which Autonomous CaMKII Increases Spine
Size. The idea that CaMKII has a structural (nonenzymatic) role was first proposed by Erondu and Kennedy (7) after it was determined that the major PSD protein is CaMKII; the nearly tight packing of CaMKII in the PSD (35) is hard to understand if the only role of the kinase is enzymatic. Our results show that the T286D mutant can enlarge spines without further kinase activity, thus providing direct evidence for a structural role of αCaMKII in this postsynaptic process. The fact that spine formation is not stimulated by tCaMKII, which is active but does not form holoenzymes, suggests that kinase activity is not sufficient, consistent with the requirement for a structural role for the holoenzyme. Alternatively, it is possible that a remaining fragment of the autoinhibitory domain of tCaMKII (1-290), although insufficient to block activity, might block a site necessary for spine size enlargement.
Such a nonenzymatic process is not inconsistent with previous work demonstrating the need for CaMKII enzymatic activity (2, 31). The overall process by which CaMKII affects spine size appears to be a two-step process. Enzymatic activity is necessary for the initiation of autophosphorylation at T286. What our results show is that, once this occurs, no further enzymatic activity is required for spine enlargement. This outcome explains why the T286A mutation does not produce spine enlargement but why kinase-dead T286D (K42R/T286D) does. This model also explains why persistent spine enlargement is prevented by pharmacological inhibition of CaM kinases (2) or by the kinase-dead form of mutant mice (K42R) (31) . Work on dissociated neurons has indicated that CaMKII-dependent phosphorylation of kalirin-7 maintains spine size (36). Our results on slice culture argue for a nonenzymatic mechanism but do not rule out Kalinrin-7 as a parallel mechanism that does require enzymatic activity.
There are several possibilities regarding how autonomous CaMKII could control spine size through a nonenzymatic process. Previous work has demonstrated that βCaMKII (which together with αCaMKII forms holoenzymes) can cross-link actin and thereby promote spine enlargement (37) . However, it is unlikely that that mechanism is involved when the α form is overexpressed (as in our experiments) because the T286A form does not produce spine enlargement. Another possible mechanism may depend on CaMKII binding to the NMDAR (38, 39) . Such binding is likely to contribute to the very high amount of CaMKII in the PSD (40, 41) that suggested a structural role for the kinase (41) . It is known that spine size and synapse size are tightly correlated (4, 42) . Thus, an interesting possibility is that synapse size is set by a structural (nonenzymatic) process that depends on the amount of CaMKII in the PSD; this, in turn, might affect binding to the cytoskeleton framework that controls spine size.
Synaptic strength and spine size covary under many physiological conditions. Our work provides an insight by showing that different CaMKII-dependent processes control synaptic strength and spine size. These pathways can, however, be dissociated; notably, some states of CaMKII increase spine size, but decrease synaptic strength. Still to be resolved is whether such weakening affects the size of the synapse itself. One possibility is that when large spines have weak synapses, the synapse is also large, maintaining the linkage of synapse size to spine size (43) . In this case, weakening must be due to a large drop in AMPA receptor density. Another possibility is that large spines have unusually small synapses. 
Materials and Methods
Organotypic Slice Culture. Hippocampal slice cultures were prepared at postnatal day 6 or 7 from Sprague-Dawley rats. The rats were decapitated in a semisterile condition, and the brain was removed. Using a slice chopper, 400-μm hippocampal slices were prepared and plated on the membrane of six-well plate inserts (Falcon; 0.4-μm pore size). Slices were incubated in a CO 2 incubator at 35°C in culture medium containing MEM (Cellgro 50-019-PB) supplemented with 20% horse serum (Sigma), 1 μg/mL insulin, 1 mM glutamine (or glutaMAX), 30 mM Hepes, 1 mM CaCl 2 , 2 mM MgSO 4 , 5 mM NaHCO 3 , 16.5 mM D-glucose, and 0.5 mM ascorbate. The culture medium was changed three times per week.
DNA Constructs. The GFP-tagged full-length αCaMKII constructs (WT, T286D) used in this study were described in ref. 44 . The GFP contained the A207K mutation to ensure its monomeric state (mGFP). K42R mutation was made by PCR amplification of mGFP-αCaMKII, using the following two mutagenesis primers: GGCCAGGAGTATGCTGCCAGGA TTATCAACACCAAGAAGC (forward) and GCTTCTTGGTGTTGATAATCCTGG CAGCATACTCCTGGCC (reverse). The K42R/T286D αCaMKII double mutant was made by restriction digest and ligation of mGFP T286D αCaMKII and mGFP K42R-αCaMKII, using EagI-HF and MfeI. All constructs were verified by sequence analysis. The truncated form (tCaMKII-GFP) was a gift from Y. Hayashi.
Transfection. After 10-15 d in vitro (DIV), SCE was used for targeted transfection as described in refs. 45 and 46. In brief, slices were transferred to an SCE chamber with rat Ringer's salt solution containing 160 mM NaCl, 5.4 mM KCl, 12 mM MgCl, 2 mM CaCl 2 , and 5 mM Hepes. The tip of the micropipette (4-5 MΩ) containing 100 ng/μL plasmid DNA in the same Ringer's solution was placed next to the soma, and 200 1-ms duration square pulses with interpulse delay of 4 ms and amplitude of 10 V were delivered. The slice cultures were returned to the incubator. Using SCE, slice cultures were (co) transfected with plasmids containing mCherry and mGFP αCaMKII variant (WT, T286A, T286D, tCaMKII, and K42R/T286D).
DST. All procedures were done in semisterile conditions, including imaging to limit contamination. SCE was performed in neurons with mCherry DNA. The next day, slices were transferred to an imaging chamber with continuous superfusion (1.8 mL/min) of sterile artificial CSF (ACSF) containing the following: 124 mM NaCl, 2.5 mM KCl, 4 mM CaCl 2 , 4 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , and 26 mM NaHCO 3 balanced with 95% O 2 and 5% CO 2 (pH 7.4) ACSF. The ROI was selected and imaged using two-photon or confocal microscopy. After imaging, slices were transferred back to the incubator for 2-3 h recovery, followed by the second SCE with GFP-αCaMKII variant. On the next day, the same ROI was imaged and analyzed as described below. Most analysis was performed blind to experimental conditions (e.g., WT, T286D, and K42R/T286D). Because the results were similar, they were combined with data obtained openly. For experiments with drug preincubation (APV), 100 μM DL-APV was added immediately after the second transfection in DST for each experiment.
Image Acquisition. Imaging was performed using a commercial Leica SP2MP or Olympus upright confocal microscope equipped with a 60× (1.1 numerical aperture, water immersion) objective, visible light (Ar/Kr) lasers, and an infrared (IR) laser (Chameleon; Coherent). GFP and mCherry were imaged in confocal mode sequentially with 488 and 543 nm excitation and 500-550 and 580-680 nm emission, respectively. Normally, stacks of 10-25 images with 0.5-μm focal steps were collected from dendritic segments. The pixel size for imaging was 0.093 μm.
Quantification of Spine Density and Volume. The spine density was estimated by the number of manually counted spines divided by dendrite segment length. To eliminate background fluorescence, a binary mask was created for each image in a given stack of z-plane images. The mask was constructed to cover all of the pixels below an arbitrarily chosen threshold equal to double the background fluorescence. ROIs were marked for laterally protruding spines. In cross-cell comparison (Fig. 1) and cross-time comparison in SI Appendix (Fig. S2) , the absolute volume was calculated from projections of three stacked sections as follows (47) . 3D Gaussian fitting was performed to fluorescent intensity of relatively large spherical mushroom spines; those of full width half maximum (FWHM) were >0.5 μm. This fitting provided the conversion factor between volume and fluorescence. Using this conversion factor, the fluorescence in other spines in the same dendritic segment was converted to volume. Spines emerging above or below the dendrite were not analyzed. In cross-time comparison (Figs. 3 and 4) , relative volume (S/D) was estimated by normalizing fluorescence of spines to that of the same dendritic segments nearby spines (SI Appendix, Fig. S4 ). Analyzed dendritic segments were not changed significantly after the second transfection (both FWHM and the dendritic volume were not significantly different: FWHM change, −1% ± 0.26%; volume change, −1% ± 0.51%; n = 182; FWHM of a dendritic segment was calculated and used as diameter of cylindrical object). These procedures were done using a custom analysis program in IGOR Pro-6 (WaveMetrics).
Electrophysiology. Slices were continuously superfused (1.8 mL/min) with artificial ACSF containing the following: 124 mM NaCl, 2.5 mM KCl, 4 mM CaCl 2 , 4 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 0.05 mM picrotoxin, and 0-1 μM 2-chloroadenosine, balanced with 95% O 2 and 5% CO 2 , pH 7.4. Whole-cell recordings were performed at room temperature (22-24°C). The pipette solution contained 120 mM Cs-methanesulfonate, 20 mM CsCl, 10 mM Hepes, 4 mM MgATP, 0.3 mM Na 3 GTP, 0.2 mM EGTA, and 5 mM Na 2 -phosphocreatine (pH 7.3), osmolarity, 320 mOsm. EPSCs were evoked by stimulating the Schaffer-collateral pathway via a stimulation electrode and measured in voltage-clamp mode at -65 mV. For cell pair recordings, two neurons (one transfected and one nontransfected) within ∼30 μm were selected. The test stimulation was delivered every 6 s with 0.2 ms duration, and the intensity (100-500 μA) was adjusted to induce 50-100 pA EPSC. After adjusting stimulation strength in one neuron, sequential recording was performed in the other neuron with the same intensity and location of stimulation. The peak amplitudes of EPSC were averaged with 30-50 sweeps. Series and input resistance was monitored throughout each experiment, and recordings for which series resistance varied by >20% were rejected.
Statistics. An ANOVA test was performed to the density analysis of crosscell comparison (Fig. 1B) . A Kolmogorov-Smirnov test was performed to the volume analysis of cross-cell comparison (Fig.1C) . Two-tailed paired Student's t tests were performed to spine density, spine volume, and spine height data involving cross-time comparisons (Figs. 2-4) . All results are reported as mean ± SEM.
